Plasma Protein Therapeutics Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2024

The report on the global plasma protein therapeutics market provides qualitative and quantitative analysis for the period from 2016 to 2024. The report predicts the global plasma protein therapeutics market to grow with a CAGR of 6.1% over the forecast period from 2018-2024. The study on plasma protein therapeutics market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2016 to 2024.

The report on plasma protein therapeutics market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global plasma protein therapeutics market over the period of 2016 to 2024. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global plasma protein therapeutics market over the period of 2016 to 2024. Further, the author's growth matrix given in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings

1. Drivers

• Growing demand of the plasma proteins derived medicines
• Continuous innovation in plasma-derived therapies

2. Restraints

• Stringent rules and regulation for plasma protein therapeutics
• Issues related to reimbursements

3. Opportunities

• Increasing demand for plasma-derived treatments
• Continuous growth in medical tourism in developing countries

Research Methodology

Primary Research

Primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include:

1. Key Opinion Leaders associated
2. Internal and External subject matter experts
3. Professionals and participants from the industry

Primary research respondents typically include:

1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.

Secondary Research

Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

Secondary sources of the data typically include:

1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segments Covered

The global plasma protein therapeutics market is segmented on the basis of product, and application.

The Global Plasma Protein Therapeutics Market by Product

• Albumins
• Immunoglobulins
• C1-esterase Inhibitors
• Hyperimmune Globulins
• Coagulation Factors

The Global Plasma Protein Therapeutics Market by Application

• Idiopathic Thrombocytopenic Purpura
• Hereditary Angioedema
• Secondary Immunodeficiency
• Primary Immunodeficiency Disorder
• Other Indications

Company Profiles

The companies covered in the report include:

• Shire
• Octapharma USA, Inc.
• Grifols, S.A.
• China Biologic Products Holdings, Inc.
• CSL Behring
• Biotest AG
• Baxter
• Chengdu Institute of Biology (CIB)

What does this report deliver?

1. Comprehensive analysis of the global as well as regional markets of the plasma protein therapeutics market.
2. Complete coverage of all the segments in the plasma protein therapeutics market to analyze the trends, developments in the global market and forecast of market size up to 2024.
3. Comprehensive analysis of the companies operating in the global plasma protein therapeutics market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. The growth matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.